David DeNardo WUSM (@denardolabwusm) 's Twitter Profile
David DeNardo WUSM

@denardolabwusm

Professor of Medicine and Immunology
Studying TME-immune interactions and immunotherapy.

ID: 1125156024

linkhttps://www.icce-wustl.org/david-denardo-lab.html calendar_today27-01-2013 14:11:47

178 Tweet

1,1K Followers

148 Following

Siteman Cancer Center (@sitemancenter) 's Twitter Profile Photo

Test Account radiation oncologist Julie Schwarz, MD, PhD, (Julie Schwarz) of Siteman has been named a William H. Danforth Washington University Physician Scholar in part for her research to develop new treatments for gynecologic cancers. siteman.wustl.edu/schwarz-named-…

<a href="/WUSTLmed/">Test Account</a> radiation oncologist Julie Schwarz, MD, PhD, (<a href="/JulieSchwarz14/">Julie Schwarz</a>) of Siteman has been named a William H. Danforth Washington University Physician Scholar in part for her research to develop new treatments for gynecologic cancers.

siteman.wustl.edu/schwarz-named-…
WashU Medicine Radiation Oncology (@washumedradonc) 's Twitter Profile Photo

We are thrilled to announce that these trainees will be joining our team!! Congrats and welcome to #radonc! #MatchRadonc #SWRO #wewhocurie #WashUMed #Match2024

We are thrilled to announce that these trainees will be joining our team!! Congrats and welcome to #radonc!

#MatchRadonc #SWRO #wewhocurie #WashUMed #Match2024
David DeNardo WUSM (@denardolabwusm) 's Twitter Profile Photo

Turns our MyCAFs become Senescent (SenCAFs) and can drive both breast and pancreas cancer progression through immune modulation. See just now online at Cancer Discovery aacrjournals.org/cancerdiscover… aacrjournals.org/cancerdiscover…

Turns our MyCAFs become Senescent (SenCAFs) and can drive both breast and pancreas cancer  progression through immune modulation. See just now online at Cancer Discovery
aacrjournals.org/cancerdiscover…
aacrjournals.org/cancerdiscover…
Elizabeth McKenna (@elizsmckenna) 's Twitter Profile Photo

Now online in Cancer Discovery: back-to-back papers from the labs of Sheila Stewart and David DeNardo WUSM on immunosuppression by senescent CAFs in breast and pancreatic cancers doi.org/10.1158/2159-8… doi.org/10.1158/2159-8… Jennifer Jiayu Ye Jad Belle #DevashishSen Test Account Siteman Cancer Center

Now online in <a href="/CD_AACR/">Cancer Discovery</a>: back-to-back papers from the labs of <a href="/sastewartlab/">Sheila Stewart</a> and <a href="/DeNardoLabWUSM/">David DeNardo WUSM</a> on immunosuppression by senescent CAFs in breast and pancreatic cancers doi.org/10.1158/2159-8… doi.org/10.1158/2159-8… <a href="/jennifer_jiayu/">Jennifer Jiayu Ye</a> <a href="/JadBelle/">Jad Belle</a> #DevashishSen <a href="/WUSTLmed/">Test Account</a> <a href="/SitemanCenter/">Siteman Cancer Center</a>
David DeNardo WUSM (@denardolabwusm) 's Twitter Profile Photo

Congratulations Dr. Liu and collaborators Beatty Lab and K.Bryant on their featured article in Science Translational Medicine. And HUDGE THANKS to PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology

Congratulations Dr. Liu and collaborators <a href="/LabBeatty/">Beatty Lab</a> and K.Bryant on their featured article in <a href="/ScienceTM/">Science Translational Medicine</a>. And HUDGE THANKS to <a href="/PanCAN/">PanCAN</a> for bringing this team together and funding the trial that came out of the science with @verastemoncology
David DeNardo WUSM (@denardolabwusm) 's Twitter Profile Photo

Congratulations Dr. Liu Siteman Cancer Center and collaborators Beatty Lab and K.Bryant on their featured article in Science Translational Medicine . And HUDGE THANKS to PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology.

Congratulations Dr. Liu <a href="/SitemanCenter/">Siteman Cancer Center</a>  and collaborators <a href="/LabBeatty/">Beatty Lab</a> and K.Bryant on their featured article in <a href="/ScienceTM/">Science Translational Medicine</a> . And HUDGE THANKS to <a href="/PanCAN/">PanCAN</a> for bringing this team together and funding the trial that came out of the science with @verastemoncology.
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

The ChampalimaudF #PancreaticCancer symposium kicks off with an opening lecture by Eileen M O’Reilly Memorial Sloan Kettering Cancer Center on the oncological landscape of available & in development Rx against PDAC. A nod to KRAS targeted therapies, including freshly presented #ENA2024 data.

The <a href="/ChampalimaudF/">ChampalimaudF</a> #PancreaticCancer symposium kicks off with an opening lecture by <a href="/EileenMOReilly/">Eileen M O’Reilly</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> on the oncological landscape of available &amp; in development Rx against PDAC. A nod to KRAS targeted therapies, including freshly presented #ENA2024 data.
OHSU Knight Cancer Institute (@ohsuknight) 's Twitter Profile Photo

Dr. Lisa Coussens (LisaCoussens@CoussensLab) is recognized for her paradigm-shifting mechanistic studies on inflammation and cancer that identified B cell and myeloid cell significance in fostering solid tumor progression and hindering therapeutic responses: bit.ly/3A3fIFL

Dr. Lisa Coussens (<a href="/coussens_lisa/">LisaCoussens@CoussensLab</a>) is recognized for her paradigm-shifting mechanistic studies on inflammation and cancer that identified B cell and myeloid cell significance in fostering solid tumor progression and hindering therapeutic responses: bit.ly/3A3fIFL
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

New #OpenAccess from Clinical Cancer Research Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic #PancreaticCancer aacrjournals.org/clincancerres/… Median OS - 13.2 months 1-year survival rate -

New #OpenAccess from <a href="/CCR_AACR/">Clinical Cancer Research</a> 
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic #PancreaticCancer
aacrjournals.org/clincancerres/…
Median OS - 13.2 months
1-year survival rate -
The Clevers Lab (@thecleverslab) 's Twitter Profile Photo

📢New human fetal pancreatic organoid model generates all three key cell types of the pancreas. New paper in Cell by Amanda Andersson Rolf , Hans Clevers and collaborators. See the article here: sciencedirect.com/science/articl…

📢New human fetal pancreatic organoid model generates all three key cell types of the pancreas. New paper in <a href="/CellCellPress/">Cell</a>  by <a href="/AmandaARolf/">Amanda Andersson Rolf</a> , <a href="/HansClevers/">Hans Clevers</a> and collaborators. See the article here:  sciencedirect.com/science/articl…
Elizabeth McKenna (@elizsmckenna) 's Twitter Profile Photo

The December issue of Cancer Discovery is now online! The cover features work by Olaf Klingbeil, Christopher Vakoc, and colleagues showing MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer - read that, the year-in-review collection, & more: aacrjournals.org/cancerdiscover…